| Direct Competitor Comparison | |
|---|
| MRK | GSK | NVS | PFE | Industry |
|---|
| Market Cap: | 138.87B | 126.48B | 182.20B | 205.42B | 64.52B |
|---|
| Employees: | 83,000 | 99,488 | 129,000 | 89,400 | 99.49K |
|---|
| Qtrly Rev Growth (yoy): | -0.09 | -0.03 | 0.02 | -0.09 | 0.11 |
|---|
| Revenue (ttm):
| 46.21B | 42.21B | 57.80B | 57.60B | 27.01B |
|---|
| Gross Margin (ttm): | 0.65 | 0.71 | 0.68 | 0.81 | 0.61 |
|---|
| EBITDA (ttm): | 16.36B | 14.49B | 17.15B | 25.34B | 10.37B |
|---|
| Operating Margin (ttm):
| 0.21 | 0.28 | 0.22 | 0.32 | 0.16 |
|---|
| Net Income (ttm): | 6.02B | 6.78B | 9.66B | 10.52B | N/A |
|---|
| EPS (ttm): | 1.96 | 2.74 | 3.94 | 2.09 | 3.27 |
|---|
| P/E (ttm): | 23.46 | 19.09 | 18.82 | 13.86 | 14.20 |
|---|
| PEG (5 yr expected): | 5.18 | 4.17 | 2.77 | 4.73 | 0.96 |
|---|
| P/S (ttm): | 3.01 | 3.00 | 3.15 | 3.57 | 2.23 |
|---|
|
| GSK = GlaxoSmithKline plc | | NVS = Novartis AG | | PFE = Pfizer Inc. | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.00 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | Private - View Profile |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | 0.00 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | Private - View Profile |
|---|
| Merck Serono S.A. | Private - View Profile |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.00 | 85.88B | 31.52 |
|---|
| MedImmune, L.L.C. | Private - View Profile |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.00 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | Private - View Profile |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.00 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private - View Profile |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.00 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | 0.00 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.00 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.00 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | 0.00 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | 0.00 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | 0.00 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | 0.00 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.00 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
0.80%